{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:22Z","timestamp":1786997602482,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Australian Governments fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.transci.2020.102947","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T23:31:08Z","timestamp":1600385468000},"page":"102947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation"],"prefix":"10.1016","volume":"59","author":[{"given":"Catherine A.","family":"Hyland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Flower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn J.","family":"Gardener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2020.102947_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.2012.09031.x","article-title":"Cyril Clarke and the prevention of rhesus haemolytic disease of the newborn","volume":"157","author":"Weatherall","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2020.102947_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.21307\/immunohematology-2019-053","article-title":"The Augustine blood group system, 48 years in the making","volume":"32","author":"Daniels","year":"2016","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2020.102947_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1631\/jzus.2006.B0161","article-title":"Genomics and world health: hopes and realities","volume":"7","author":"Weatherall","year":"2006","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.transci.2020.102947_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAT.0000000000000225","article-title":"Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia","volume":"47","author":"Pal","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.transci.2020.102947_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2020.102947_bib0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/blood-2008-11-146860","article-title":"Red cell genotyping and the future of pretransfusion testing","volume":"114","author":"Anstee","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transci.2020.102947_bib0035","series-title":"Red cell immunogenetics and blood group terminology","author":"ISBT Terminology Committee","year":"2020"},{"key":"10.1016\/j.transci.2020.102947_bib0040","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/trf.12973","article-title":"SARA: a \"new\" low-frequency MNS antigen (MNS47) provides further evidence of the extreme diversity of the MNS blood group system","volume":"55","author":"McBean","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27014","article-title":"Molecular characterization and multidisciplinary management of Gerbich hemolytic disease of the newborn","volume":"65","author":"Levitt","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2020.102947_bib0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cjp2.33","article-title":"Genotyping confirms inheritance of the rare At(a-) type in a case of haemolytic disease of the newborn","volume":"2","author":"McBean","year":"2016","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.transci.2020.102947_bib0055","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2020.102947_bib0060","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","article-title":"Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma","volume":"339","author":"Lo","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2020.102947_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1318.019","article-title":"A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma","volume":"1022","author":"Finning","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.transci.2020.102947_bib0070","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study","volume":"336","author":"Finning","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2020.102947_bib0075","doi-asserted-by":"crossref","first-page":"E8159","DOI":"10.1073\/pnas.1615800113","article-title":"Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends","volume":"113","author":"Chan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.transci.2020.102947_bib0080","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1373\/clinchem.2008.111385","article-title":"Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma","volume":"54","author":"Lun","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.transci.2020.102947_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.blre.2005.04.002","article-title":"Rh proteins: key structural and functional components of the red cell membrane","volume":"20","author":"Van Kim","year":"2006","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2020.102947_bib0090","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1182\/blood.V78.10.2747.2747","article-title":"Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis","volume":"78","author":"Colin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.transci.2020.102947_bib0095","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V95.12.3662.012k12_3662_3668","article-title":"RHD gene deletion occurred in the Rhesus box","volume":"95","author":"Wagner","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.transci.2020.102947_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21307\/immunohematology-2019-419","article-title":"Review: the molecular basis of the Rh blood group phenotypes","volume":"20","author":"Wagner","year":"2004","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2020.102947_bib0105","series-title":"Human blood groups","author":"Daniels","year":"2013"},{"key":"10.1016\/j.transci.2020.102947_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2020.102947_bib0115","series-title":"The management of women with red cell antibodies during pregnancy. RCOG green-top guideline, gynaecologists:, R.C.o.O.a. (2014) the management of women with red cell antibodies during pregnancy. Green-top guideline No. 65 \u00a9","author":"Gynaecologists","year":"2014"},{"key":"10.1016\/j.transci.2020.102947_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2020.102947_bib0125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pd.5355","article-title":"The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization","volume":"38","author":"Zwiers","year":"2018","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.transci.2020.102947_bib0130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12884-019-2525-y","article-title":"Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital","volume":"19","author":"Sanchez-Duran","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.transci.2020.102947_bib0135","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1537-2995.2008.01843.x","article-title":"The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible","volume":"48","author":"M\u00fcller","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0140","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pd.4419","article-title":"Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark","volume":"34","author":"Clausen","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.transci.2020.102947_bib0145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/voxs.12521","article-title":"Cell-free fetal DNA and fetal blood group genotyping: non-invasive prenatal testing","volume":"15","author":"Clausen","year":"2020","journal-title":"ISBT Sci Ser"},{"key":"10.1016\/j.transci.2020.102947_bib0150","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ajog.2006.07.033","article-title":"Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood\u2014a meta-analysis","volume":"195","author":"Geifman-Holtzman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.transci.2020.102947_bib0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1471-0528.14050","article-title":"The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis","volume":"124","author":"Mackie","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2020.102947_bib0160","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3109\/14767058.2014.882306","article-title":"Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis","volume":"27","author":"Zhu","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.transci.2020.102947_bib0165","doi-asserted-by":"crossref","first-page":"g5243","DOI":"10.1136\/bmj.g5243","article-title":"Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study","volume":"349","author":"Chitty","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2020.102947_bib0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/pd.4253","article-title":"Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping","volume":"34","author":"Hyland","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.transci.2020.102947_bib0175","series-title":"Cell-free placental DNA beyond Down syndrome lessons learned from fetal RHD genotyping","author":"Thurik","year":"2016"},{"key":"10.1016\/j.transci.2020.102947_bib0180","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1373\/clinchem.2019.307074","article-title":"Amplicon sequencing-based noninvasive fetal genotyping for RHD-positive D antigen-negative alleles","volume":"65","author":"Takahashi","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.transci.2020.102947_bib0185","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2011.03028.x","article-title":"Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","volume":"118","author":"Scheffer","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2020.102947_bib0190","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1373\/clinchem.2006.074997","article-title":"Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis","volume":"52","author":"Chan","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.transci.2020.102947_bib0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5694\/j.1326-5377.2009.tb02668.x","article-title":"Evaluation of non-invasive prenatal RHD genotyping of the fetus","volume":"191","author":"Hyland","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.transci.2020.102947_bib0200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/vox.12768","article-title":"Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop","volume":"114","author":"Clausen","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2020.102947_bib0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/trf.15054","article-title":"Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature","volume":"59","author":"Li","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tmrv.2010.11.003","article-title":"Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned?","volume":"25","author":"Heathcote","year":"2011","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2020.102947_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2013.10.002","article-title":"Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature","volume":"28","author":"Yasuda","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.transci.2020.102947_bib0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajog.2015.01.049","article-title":"Hemolytic disease of the fetus and newborn due to multiple maternal antibodies","volume":"213","author":"Markham","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.transci.2020.102947_bib0225","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0230","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2011.03028.x","article-title":"Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","volume":"118","author":"Scheffer","year":"2011","journal-title":"BJOG: Int J Obstet Gynaecol"},{"key":"10.1016\/j.transci.2020.102947_bib0235","series-title":"International Blood Group Reference Laboratory Request for fetal blood group genotyping from maternal blood","author":"NHS Blood and Transplant","year":"2017"},{"key":"10.1016\/j.transci.2020.102947_bib0240","series-title":"Non-invasive fetal genotyping. p. Request form","author":"Sanquin Diagnostic Services","year":"2017"},{"key":"10.1016\/j.transci.2020.102947_bib0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-019-2525-y","article-title":"Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital","volume":"19","author":"S\u00e1nchez-Dur\u00e1n","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.transci.2020.102947_bib0250","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230552","article-title":"Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition","volume":"12","author":"Yu","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.transci.2020.102947_bib0255","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/trf.15709","article-title":"Fetal inheritance of GP*Mur causing severe HDFN in an unrecognized case of maternal alloimmunization","volume":"60","author":"Mallari","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0260","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/NPM-16131","article-title":"Intravenous immunoglobulin in the management of a rare cause of hemolytic disease of the newborn: anti-SARA antibodies","volume":"10","author":"Venkataraman","year":"2017","journal-title":"J Neonatal Perinatal Med"},{"key":"10.1016\/j.transci.2020.102947_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.102708","article-title":"Recent advances in non-invasive fetal HPA-1a typing","volume":"59","author":"Nogues","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2020.102947_bib0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000505161","article-title":"Potential of next-generation sequencing in noninvasive fetal molecular blood group genotyping","volume":"47","author":"Wienzek-Lischka","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2020.102947_bib0275","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/pd.4230","article-title":"Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G&A) allele","volume":"33","author":"Tsui","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.transci.2020.102947_bib0280","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1373\/clinchem.2015.239137","article-title":"Fetal sex and RHD genotyping with digital PCR demonstrates greater sensitivity than real-time PCR","volume":"61","author":"Sillence","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.transci.2020.102947_bib0285","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/bjh.16500","article-title":"Non-invasive prenatal testing (NIPT) for fetal Kell, Duffy and Rh blood group antigen prediction in alloimmunised pregnant women: power of droplet digital PCR","volume":"189","author":"O\u2019Brien","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2020.102947_bib0290","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/trf.12172","article-title":"Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma","volume":"53","author":"Rieneck","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0295","article-title":"Noninvasive antenatal determination of fetal blood group using next-generation sequencing","volume":"6","author":"Rieneck","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.transci.2020.102947_bib0300","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/trf.15116","article-title":"Prediction of fetal blood group and platelet antigens from maternal plasma using next-generation sequencing","volume":"59","author":"Orzi\u0144ska","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2020.102947_bib0305","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000505161","article-title":"Potential of next-generation sequencing in noninvasive fetal molecular blood group genotyping","volume":"47","author":"Wienzek-Lischka","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2020.102947_bib0310","unstructured":"http:\/\/www.isbtweb.org\/working-parties\/red-cell-immunogenetics-and-blood-group-terminology\/."},{"issue":"4","key":"10.1016\/j.transci.2020.102947_bib0315","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000504348","article-title":"Introduction of Noninvasive Prenatal Testing for Blood Group and Platelet Antigens from Cell-Free Plasma DNA Using Digital PCR","volume":"47","author":"Eryilmaz","year":"2020","journal-title":"Transfusion Medicine and Hemotherapy"},{"key":"10.1016\/j.transci.2020.102947_bib0320","unstructured":"https:\/\/ranzcog.edu.au\/RANZCOG_SITE\/media\/RANZCOG-MEDIA\/Women%27s%20Health\/Statement%20and%20guidelines\/Clinical%20-%20Gynaecology\/RCOG-The-Management-of-Women-with-Red-Cell-Antibodies-during-Pregnancy-(Green-top-65).pdf?ext=.pdf https:\/\/ranzcog.edu.au\/RANZCOG_SITE\/media\/RANZCOG-MEDIA\/Women%27s%20Health\/Statement%20and%20guidelines\/Clinical%20-%20Gynaecology\/RCOG-The-Management-of-Women-with-Red-Cell-Antibodies-during-Pregnancy-(Green-top-65).pdf?ext=.pdf12014 2014."}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220302639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220302639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:50Z","timestamp":1761468710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220302639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1473050220302639"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102947","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102947"}}